Last week I went to Germany to talk to a pharmaceutical company about my work on the blood protein, human serum albumin. It set me thinking. But first I need to tell you about albumin. Albumin is a surprisingly abundant protein in the human body;
Last week I went to Germany to talk to a pharmaceutical company about my work on the blood protein, human serum albumin. It set me thinking. But first I need to tell you about albumin. Albumin is a surprisingly abundant protein in the human body;
I gave a talk a couple of weeks ago at a Biochemical Society meeting on the subject of the Research Excellence Framework, the process that will assess UK academic research quality for the purpose of determining how a large tranche of public funding will be distributed between universities. I dealt in particular with the impact component, which will count for 20% of the assessment and has caused a degree of consternation.
In UK scientific circles and the wider realm of academia impact has been around for a while now. Grant forms incorporate large blank spaces in which applicants are required to outline their plans for ensuring that the work they hope to do will have impact.